LANTERN PHARMA INC. (LTRN) Operating income 2021–2025
LANTERN PHARMA INC. (LTRN) annual operating income history from SEC filings — each fiscal year as reported.
-$18.0MFY2025 · since FY2021: -$12.6M → -$18.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$18.0M | +19.1% |
| FY2024 | -$22.2M | -24.3% |
| FY2023 | -$17.9M | -23.9% |
| FY2022 | -$14.4M | -14.6% |
| FY2021 | -$12.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More LTRN financial trends
LTRN RevenueLTRN Net incomeLTRN Net marginLTRN Gross profitLTRN Gross marginLTRN Operating marginLTRN Operating cash flowLTRN Free cash flowLTRN Capital expendituresLTRN Return on equityLTRN Stock buybacksLTRN Dividends paidLTRN Total assetsLTRN Total liabilitiesLTRN Shareholders’ equityLTRN overview →